About Certara, Inc. - CERT
Certara, Inc. is a company specializing in biosimulation technologies, providing software products and services to support decision-making in the drug development process for pharmaceutical and biotechnology companies. Their tools and solutions are designed to predict how drugs behave in the body and how they will affect patients, thus aiming to improve the efficiency of drug discovery and development.
What are Certara, Inc.'s core values and mission statement?
Certara's mission is to harness the power of biosimulation and regulatory science to advance the discovery, development, and delivery of safe and effective therapies. Their core values focus on scientific excellence, innovation, and collaboration to support decision-making and drive improved health outcomes.
Who founded Certara, Inc. and when?
Certara, Inc. was co-founded by Jim Hopkins and Thomas Miller in 2008.
Who leads Certara, Inc.?
As of my last update, Certara, Inc. was led by CEO William F. Feehery. Please refer to the most current sources to confirm if there have been any changes in leadership.
Where is Certara, Inc. located, and what is its base country?
Certara, Inc. is headquartered in Princeton, New Jersey, USA, which is its base country.
On which exchanges is Certara, Inc. traded?
Certara, Inc. is traded on the Nasdaq Stock Market under the ticker symbol "CERT."
Certara, Inc. (CERT) Price Live Data
The live price of Certara, Inc. (CERT) is $16.88, with a trading volume of 26,397 in the last 24 hours. Wrapstocks updates the CERT price in real-time. Certara, Inc. is down -0.36% in the last 24 hours. The company has a live market cap of $2,698,183,424.00 and a supply of 159,844,990 CERT stocks.
Certara, Inc. (CERT) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 5 hours and 38 minutes.